ATOSSA THERAPEUTICS, INC. — Director's Dealing 2014

Feb 14, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2013-12-31

Reporting Person: QUAY STEVEN C (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-28	Common Stock	G	1000	—	Disposed	583543	Direct
2013-07-18	Common Stock	G	100000	—	Disposed	483543	Direct
2013-07-18	Common Stock	G	5000	—	Disposed	478543	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4268315	Indirect

Footnotes

F1: Ensisheim Partners, LLC is wholly-owned by the Reporting Person and Dr. Shu-Chih Chen, the Chief Scientific Officer of the Issuer. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of all such securities for purposes of Section 16 or any other purpose.